Impact of Different Embolic Agents for Transarterial Chemoembolization (TACE) Procedures on Systemic Vascular Endothelial Growth Factor (VEGF) Levels

Background and Aims: Intermediate stage hepatocellular carcinoma (HCC) can be treated by transarterial chemoembolization (TACE). However, there appear to be side effects, such as induction of proangiogenic factors, e.g. vascular endothelial growth factor (VEGF), which have been shown to be associate...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:J Clin Transl Hepatol
Glavni autori: Schicho, Andreas, Hellerbrand, Claus, Krüger, Kristina, Beyer, Lukas P., Wohlgemuth, Walter, Niessen, Christoph, Hohenstein, Ernst, Stroszczynski, Christian, Pereira, Philippe L., Wiggermann, Philipp
Format: Artigo
Jezik:Inglês
Izdano: XIA & HE Publishing Inc. 2016
Teme:
Original Article
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5225147/
https://ncbi.nlm.nih.gov/pubmed/28097096
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.14218/JCTH.2016.00058
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items